These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10713643)

  • 1. Usefulness of detection of complement activation products in evaluating SLE activity.
    Nagy G; Brózik M; Varga L; Füst G; Kirschfink M; Kiss E; Gergely P
    Lupus; 2000; 9(1):19-25. PubMed ID: 10713643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in patients with systemic lupus erythematosus without nephritis.
    Mollnes TE; Haga HJ; Brun JG; Nielsen EW; Sjöholm A; Sturfeldt G; Mårtensson U; Bergh K; Rekvig OP
    Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP; Ruddy S; Schwartz LB; Moxley G
    Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.
    Buyon JP; Tamerius J; Belmont HM; Abramson SB
    Arthritis Rheum; 1992 Sep; 35(9):1028-37. PubMed ID: 1418018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
    Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
    Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1r-C1s-C1inhibitor (C1rs-C1inh) complex measurements in tears of patients before and after penetrating keratoplasty.
    Kerényi A; Nagy G; Veres A; Varga L; Füst A; Nagymihány A; Czumbel N; Süveges I; Füst G
    Curr Eye Res; 2002 Feb; 24(2):99-104. PubMed ID: 12187480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
    Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
    Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin treatment activates complement in vivo.
    Mollnes TE; Høgåsen K; De Carolis C; Vaquero E; Nielsen EW; Fontana L; Perricone R
    Scand J Immunol; 1998 Sep; 48(3):312-7. PubMed ID: 9743219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ELISA for detection of SC5b-9 levels in plasma and its clinical significance in SLE disease].
    Kan D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):302-5. PubMed ID: 8168211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation.
    Takematsu H; Tagami H
    Tohoku J Exp Med; 1991 Apr; 163(4):263-8. PubMed ID: 1831937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
    Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
    Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
    Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
    Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples.
    Kolb WP; Morrow PR; Tamerius JD
    Complement Inflamm; 1989; 6(3):175-204. PubMed ID: 2472921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement components and their activation products in pleural fluid.
    Salomaa ER; Viander M; Saaresranta T; Terho EO
    Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.